Literature DB >> 12522031

Herpesvirus infections in organ transplant recipients.

Frank J Jenkins1, David T Rowe, Charles R Rinaldo.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12522031      PMCID： PMC145294          DOI： 10.1128/cdli.10.1.1-7.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN： 1071-412X


× No keyword cloud information.
  113 in total

Review 1.  The importance of specific virus diagnosis and monitoring for antiviral treatment.

Authors:  A Linde
Journal:  Antiviral Res       Date:  2001-08       Impact factor: 5.970

2.  Treatment of post-transplant lymphoproliferative disorder with monoclonal CD20 antibody (rituximab) after heart transplantation.

Authors:  N D Zilz; L J Olson; C G McGregor
Journal:  J Heart Lung Transplant       Date:  2001-07       Impact factor: 10.247

3.  Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation.

Authors:  Amelia A Langston; Istvan Redei; Angela M Caliendo; Jyoti Somani; Don Hutcherson; Sagar Lonial; Silvana Bucur; Judy Cherry; Andrew Allen; Edmund K Waller
Journal:  Blood       Date:  2002-02-01       Impact factor: 22.113

Review 4.  Challenges and options in the management of viral infections after stem cell transplantation.

Authors:  Pierre Reusser
Journal:  Support Care Cancer       Date:  2001-09-22       Impact factor: 3.603

5.  Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children.

Authors:  A Faye; P Quartier; Y Reguerre; P Lutz; A S Carret; A Dehée; P Rohrlich; M Peuchmaur; A Matthieu-Boué; A Fischer; E Vilmer
Journal:  Br J Haematol       Date:  2001-10       Impact factor: 6.998

6.  Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication.

Authors:  Erik A M Verschuuren; Servi J C Stevens; Gustaaf W van Imhoff; Jaap M Middeldorp; Conny de Boer; Gerard Koëter; T Hauw The; Wim van Der Bij
Journal:  Transplantation       Date:  2002-01-15       Impact factor: 4.939

Review 7.  Prevention and treatment of cytomegalovirus infection in organ transplant recipients.

Authors:  S Kusne; R Shapiro; J Fung
Journal:  Transpl Infect Dis       Date:  1999-09       Impact factor: 2.228

Review 8.  Recent developments in herpesvirus therapy.

Authors:  L Naesens; E De Clercq
Journal:  Herpes       Date:  2001-03

9.  Monitoring of viral load by quantitative plasma PCR during active cytomegalovirus infection of individual liver transplant patients.

Authors:  Heli Piiparinen; Krister Höckerstedt; Maija Lappalainen; Jukka Suni; Irmeli Lautenschlager
Journal:  J Clin Microbiol       Date:  2002-08       Impact factor: 5.948

10.  Reactivation of and primary infection with human herpesvirus 8 among solid-organ transplant recipients.

Authors:  Frank J Jenkins; Linda J Hoffman; Angela Liegey-Dougall
Journal:  J Infect Dis       Date:  2002-04-09       Impact factor: 5.226
View more
  8 in total

1.  Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay.

Authors:  Kaoru Wada; Naomi Kubota; Yoshinori Ito; Hiroshi Yagasaki; Koji Kato; Tetsushi Yoshikawa; Yasuyuki Ono; Hisami Ando; Yasuhiro Fujimoto; Tetsuya Kiuchi; Seiji Kojima; Yukihiro Nishiyama; Hiroshi Kimura
Journal:  J Clin Microbiol       Date:  2007-03-21       Impact factor: 5.948

2.  Salivary shedding of Epstein-Barr virus and cytomegalovirus in people infected or not by human immunodeficiency virus 1.

Authors:  Talita Ribeiro Tenório de França; Alessandra de Albuquerque Tavares Carvalho; Valder Barbosa Gomes; Luiz Alcino Gueiros; Stephen Ross Porter; Jair Carneiro Leao
Journal:  Clin Oral Investig       Date:  2011-03-29       Impact factor: 3.573

3.  Immunogenicity of parathyroid allografts in the rat: immunosuppressive dosages effective in passenger leukocyte-rich small bowel transplants are not effective in parathyroid gland transplants with few passenger leukocytes.

Authors:  S Timm; C Otto; D Begrich; V Moskalenko; W Hamelmann; K Ulrichs; A Thiede; W Timmermann
Journal:  Langenbecks Arch Surg       Date:  2003-12-05       Impact factor: 3.445

Review 4.  Hijacking GPCRs by viral pathogens and tumor.

Authors:  Junjie Zhang; Hao Feng; Simin Xu; Pinghui Feng
Journal:  Biochem Pharmacol       Date:  2016-04-06       Impact factor: 5.858

Review 5.  Mesenchymal Stromal Cells and Viral Infection.

Authors:  Maytawan Thanunchai; Suradej Hongeng; Arunee Thitithanyanont
Journal:  Stem Cells Int       Date:  2015-07-29       Impact factor: 5.443

6.  Two fatal herpesvirus cases: Treatable but easily missed diagnoses.

Authors:  Christine Bookhout; Vincent Moylan; Leigh B Thorne
Journal:  IDCases       Date:  2016-09-23

7.  HSV-1 Glycoproteins Are Delivered to Virus Assembly Sites Through Dynamin-Dependent Endocytosis.

Authors:  Anna Albecka; Romain F Laine; Anne F J Janssen; Clemens F Kaminski; Colin M Crump
Journal:  Traffic       Date:  2015-11-06       Impact factor: 6.215

8.  Viruses and atypical bacteria in the respiratory tract of immunocompromised and immunocompetent patients with airway infection.

Authors:  Maria Reckziegel; Claudia Weber-Osel; Roland Zell; Andi Krumbholz; Renate Egerer; Bernd Gruhn; Florian Kubek; Mario Walther; Stefanie Wilhelm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-05-27       Impact factor: 3.267
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.